Global Chronic Wound Care Market is Segmented By Product Type(Advanced Wound Dressing (Foams Dressings, Hydrogel Dressings, Collagen Dressings, Other Dressings, Active Wound Care (Skin-grafts, Growth Factors, Therapy Devices (Negative Pressure Wound Therapy Devices, Pressure Relief Devices, Hyperbaric Oxygen Equipment, Other Devices), By Wound Type (Diabetic Foot Ulcer, Pressure Ulcer, Arterial and Venous Ulcer, Others), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Chronic Wound Care Market Overview
Global Chronic Wound Care market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
A chronic wound is a wound that does not recover in an orderly set of phases and in a predictable amount of period or injuries that do not recover within three months are usually regarded chronic. Chronic wounds usually stay in the inflammatory phase for too long and may never recover or may take years.
Chronic Wound Care Market Scope
Metrics |
Details |
CAGR |
YY% |
Market Size Available for Years |
2022-2031 |
Estimation Forecast Period |
2024-2031 |
Revenue Units |
Value (US$ Mn) |
Segments Covered |
Product Type, Wound Type, End User |
Regions Covered |
North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
Largest Region |
North America |
Fastest Growing Region |
Asia-Pacific |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Market Dynamics: Drivers & Restraints
Advanced Product Development and New Product Introductions
The advanced product development and new product introductions into the market are expected to boost the global market growth during the forecast period. For instance, in October 2023, Healiva developed EpiDex autologous epidermis patches for the therapy of chronic wounds, based on cells originating from a patient’s hair strands.
Moreover, in October 2022, Healthium Medtech introdined a new wound dressing product line, Theruptor Novo, for the control of chronic wounds such as diabetic foot ulcers and leg ulcers. Additionally, the rise in diabetes ulcer and vascualr ulcer cases cases and growing market developments are among other factors that are expected to contribute to the global market growth during the forecast period.
High Treatment Cost
Nevertheless, the high cost of wound care treatment since the treatment runs for longer duration is hampering the global market growth along with the others factors including stringent regulations for approval from regulatory authorities, high development costs and lack of professionals hampering the global market growth during the forecast period.
Chronic Wound Care Market Segment Analysis
The global chronic wound care market is segmented based on product type, wound type, end user and region.
Foam Dressing Product Type is Expected to Dominate Market
Foam Dressings are expected to dominate the global market during the forecast period owing to increasing product introductions in the segment. For instance, in June 2022, Medline introduced its OptifoamGentle EX Foam Dressing. When united with a pressure injury prevention protocol, the development is purposed to assist in deposing pressure. Moreover, in May 2022, Winner Medical revealed its latest and industry-leading cutting-edge surgical wound care developments, such as the Transparent Film Dressing, Bordered Silicone Foam Dressing with SAF and Antibiosis Series Products, and the Carboxymethylcellulose (CMC) dressing.
Geographical Analysis
North America is Expected to Dominate the Global Market
Owing to the increasing cases of diabetes, pressure injuries, and the increasing market developments are expected to boost the North America market to dominate the global market during the forecast period. For instance, according to the International Diabetes Federation Diabetes Atlas Tenth Edition, in 2021, about 32.2 million individuals in the United States had diabetes, which is projected to increase to 36.3 million by 2045.
Moreover, according to the National Center for Biotechnology Information report, in December 2021 a significant number of 1.0 to 3.0 million individuals in the U.S. suffered from pressure injuries, emphasizing the requirement for efficacious wound management solutions. Further, in April 2023 Kane Biotech formed a distribution arrangement with ProgenaCare Global for its coactive antimicrobial wound gel to get technology to the wound care and surgical markets in the U.S. with an emphasis on inexpensive and effective wound care technologies.
COVID-19 Impact Analysis
Delayed wound care was of special consideration during the COVID‐19 pandemic. Since they usually have underlying comorbidities like diabetes, chronic wound patients are at improved threat for more threatening COVID‐19 consequences in the duration of hospitalization and death. However, post-pandemic the situation is returning to pre-pandemic conditions.
Key Developments
- In September 2022, Evonik formed an agreement with the medical technology consulting and sales corporation Coopmed for the distribution of the wound dressing Epicite.
- In September 2023, Healiva formed a strategic collaboration with Lausanne University Hospital (CHUV, ‘Centre Hospitalier Universitaire Vaudois’) for the manufacturing and clearance of its autologous epidermal equivalent, Epidex.
- In July 2022 Smith Nephew introduced its clinical support app WOUND COMPASS. The complete digital asset tool for clinicians in injury review and decision-making to decrease variation in practice.
Competitive Landscape
The major global players in the market include 3M Company, Cardinal Health Inc., Coloplast AS, B. Braun SE, Integra Lifesciences, Smith & Nephew, ConvaTec Group PLC, Mölnlycke Health Care AB, Johnson & Johnson and Medtronic Plc. among others.
Why Purchase the Report?
- To visualize the global chronic wound care market segmentation based on product type, wound type, end user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of chronic wound care market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global chronic wound care market report would provide approximately 61 tables, 58 figures and 184 pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies